Thus, a useful way to think of amyloid diseases is that the normal control mechanisms carefully set up by evolution to prevent aggregation have failed.
The University of Colorado researchers are studying molecular mechanisms of normal acclimatization in healthy people to gain new treatment ideas for people with chronic obstructive pulmonary disease, or COPD, a common lung disease.